This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03124/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03124/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB03124/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03124/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03124/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03124
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB03124 n14:DB03124
dcterms:title
5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid
adms:identifier
n6:4449814 n7:DB03124 n10:46505887 n12:161 n13:5287429
n3:IUPAC-Name
n4:271B5154-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B515A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5159-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5156-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5157-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5158-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5152-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5150-363D-11E5-9242-09173F13E4C5 n4:271B5153-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5151-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5160-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5161-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B515B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B515C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B515E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B515D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B515F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5166-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5168-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5169-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5165-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5164-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5167-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5155-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5162-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5163-363D-11E5-9242-09173F13E4C5